Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

Background The aim of this study was to investigate whether bioactive adrenomedullin (bio-ADM) and interleukin-6 (IL-6) are related to acute kidney injury (AKI) and severe illness in COVID-19 patients. Methods 153 patients with COVID-19 admitted to the emergency department (ED) were included. Blood...

Descripción completa

Detalles Bibliográficos

Autores principales:	Simon B. Leininger, Stephan T. Staudner, Manuel J. Vogel, Julian Mustroph, Ute Hubauer, Stefan Wallner, Petra Lehn, Ralph Burkhardt, Christine Meindl, Frank Hanses, Markus Zimmermann, Lars S. Maier, Julian Hupf, Carsten G. Jungbauer
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2024-02-01
Colección:	BMC Nephrology
Materias:	COVID-19 SARS-CoV-2 Adrenomedullin Interleukin-6 Acute Kidney Injury
Acceso en línea:	https://doi.org/10.1186/s12882-024-03486-1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!